PDCD5 interacts with ti|i60 and functions as a cooperator in acetyltransferase activity and dima damage- induced apoptosis1 2 www.neoplasia.com

Neoplasia

Volumn 11, Issue 4, 2009, Pages 345-354

  Xu, Lanjun ^a,b   Chen, Yingyu ^a,b   Song, Quansheng ^a,b   Xu, Dong ^a,b   Wang, Ying ^a,b   Ma, Dalong ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; PROTEIN; PROTEIN BAX; PROTEIN P53; PROTEIN TIP60; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; HTATIP PROTEIN, HUMAN; PDCD5 PROTEIN, HUMAN; TUMOR PROTEIN;

ACCELERATION; ACETYLATION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; ULTRAVIOLET IRRADIATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACETYLATION; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; DNA DAMAGE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HISTONE ACETYLTRANSFERASES; HUMANS; IMMUNOPRECIPITATION; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65549141207     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.81524     Document Type: Article

References (37)

1. Kamine J, Elangovan B, Subramanian T, Coleman D, and Chinnadurai G (1996). Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-I Tat transactivator. Virology 216, 357-366.
2. Kimura A and Horikoshi M (1998). Tip60 acetylates six lysines of a specific class in core histones in vitro. Genes Cells 3, 789-800.
3. Yamamoto Tand Horikoshi M (1997). Novel, substrate specificity of the histone acetyltransferase activity of HIV-1-Tat interactive protein Tip60. J. Biol Chem 272, 30595-30598.
4. Kusch T, Florens L, Macdonald WH, Swanson SK, Glaser RL, Yates JR III, Abmayr SM, Washburn MP, and Workman JL (2004). Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 306, 2084-2087.
5. Sapountzi V, Logan IR, and Robson CN (2006). Cellular functions of TIP60. Int J Biochem Cell Biol 38, 1496-1509.
6. Gaughan L, Logan IR, Cook S, Neal DE, and Robson CN (2002). Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. /Biol Chem 277, 25904-25913.
7. Patel JH, Du Y, Ard PG, Phillips C, Carella B, Chen CJ, Rakowski C, Chatterjee C, Lieberman PM, Lane WS, et al. (2004). The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TI. P60. MoI Cell Biol 24, 10826-10834.
8. Xiao H, Chung J, Kao HY, and Yang YC (2003). Tip60 is a co-repressor for STAT3. J. Biol Chem 278, 11197-11204.
9. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, and Rosenfeld MG (2002). Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110, 55-67.
10. Taubert S, Gorrini C, Frank SR, Parisi. T, Fuchs M, Chan HM, Livingston DM, and Amati B (2004). E2F-dependent histone acetylation and. recruitment of the Tip60 acetyltransferase complex to chromatin in late Gi. MoI Cell Biol 24, 4546-4556.
11. DeRan M, Pulvino M, Greene E, Su C, and Zhao J (2008). Transcriptional ac- tivation of histone genes requires NPAT-dependent recruitment of TRRAP-Tip60 complex to histone promoters during the Gj/S phase transition. MoI Cell Biol 26, 435-447.
12. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, et al. (2004). A large-scale RNAi screen in. human cells identifies new components of the p53 pathway. Nature 428, 431.-437.
13. Legube G, Linares LK, Tyteca S, Caron C, Scheffner M, Chevillard-Briet M, and Trouche D (2004). Role of the histone acetyl transferase Tip60 in the p53 pathway. J. Biol Chem 279, 44825-44833.
14. Doyon Y, Selleck W, Lane WS, Tan S, and Cote J (2004). Structural and func- tional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. MoI CellBiollA, 1884-1896. (Pubitemid 38248930)
15. Murr R, Loizou JI, Yang YG, Cuenin C, Li H, Wang ZQ and Herceg Z (2006). Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks. Nat Cell Biol 6, 91-99.
16. Liu H, Wang Y, Zhang Y, Song Q, Di C, Chen G, Tang J, and Ma D (1999). TFARlS), a novel apoptosis-related gene cloned from human leukemia cell line TF-I, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254, 203-210.
17. Wang Y, Li X, Wang L, Ding P, Zhang Y, Han W, and Ma D (2004). An alter- native form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by P. DC. D5 overexpression. /CfA Sei 117, 1525-1532.
18. Chen Y, Sun R, Han W, Zhang Y, Song Q Di C, and Ma D (2001). Nudear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett 509, 191-196. [1.9] Ma X, Ruan G, Wang Y, Li Q, Zhu P, Qin YZ, Li JL, Liu YR, Ma D, and Zhao H (2005). Two singl.e-nucleot.ide polymorphisms with, linkage disequilibrium, in the human programmed cell death 5 gene 5' regulatory region affect promoter activ- ity and. the susceptibility of chronic myelogenous leukemia in. Chinese population. Clin Cancer Res 11, 8592-8599.
19. Spinola M, Meyer P, Kämmerer S, Falvella FS, Boettger MB, Hoyal CR, Pignatiello C, Fischer R, Roth RB, Pastorino U, et al. (2006). Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. J. Clin Oncol 24, 1672-1678.
20. Hedenfklk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, et al. (2001). Gene-expression pro- files in hereditary breast cancer. N Engl J Med 344, 539-548.
21. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, et al. (2001). Insight into hepatocellular carcinogenesis at transcrip- tome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sei USA 98, 15089-15094.
22. Yang YH, Zhao M, Li WM, Lu YY, Chen YY, Kang B, and Lu YY (2006). Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis 11, 993-1001.
23. Rúan GR, Qin YZ, Chen SS, Li JL, Ma X, Chang Y, Wang YZ, Fu JY, and Liu YR (2006). Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk Res 30, 1159-1165.
24. Li H1 Wang Q, Gao F, Zhu F, Wang X, Zhou C, Liu C, Chen Y, Ma C, Sun W, et al. (2008). Reduced expression of P. DCD5 is associated with high-grade astrocytic gliomas. Oncol Rep 20, 573-579.
25. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, et al. (2005). A human protein-protein interaction network: a resource for annotating the proteome. CeU 122, 957-968.
26. Chen LN, Wang Y, Ma DL, and Chen YY (2006). Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax over- expression. Apoptosis 11, 101-111.
27. Bannister AJ and. Kouzarides T (1996). The CBP co-activator is a histone acetyl- transferase. Nature 384, 641-643. (Pubitemid 27021517)
28. Legube G, Linares LK, Lemercier C, Scheffner M, Khochbin S, and Trouche D (2002). Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation. EMBO/21, 1704-1712.
29. Logan IR, Sapountzi V, Gaughan L, Neal DE, and Robson CN (2004). Control of human PIRH2 protein stability: involvement of TIP60 and the proteosome. J Biol Chem 12, 11696-11704.
30. Halkidou K, Logan IR, Cook S, Neal DE, and Robson CN (2004). Putative involvement of the histone acetyltransferase Tip60 in ribosomal gene transcription. Nucleic Acids Res 32, 1.654-1.665.
31. Cheng Z, Ke Y, Ding X, Wang F, Wang H, Wang W, Ahmed K, Liu Z, Xu Y, Aikhionbare F, et al. (2008). Functional characterization of TIP60 sumoylation in UV-irradiated DNA damage response. Oncogene 27 (7), 931-941.
32. Sykes SM, Meliert HS, Holbert MA, Li K, Marmorstein R, Lane WS, and McMahon SB (2006). Acetylation of the p53 DNA-binding domain regulates apoptosis induction. MoI Cell 24, 841-851.
33. Ikura T, Ogryzko W, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J, and Nakatani Y (2000). Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 102, 463-473.
34. Tyteca S, Vandromme M, Legube G, Chevi.llard-B.riet M, and Trouche D (2006). Tip60 and p400 are both, required for UV-induced apoptosis but play antagonistic roles in cell cycle progression. EMBO J 25, 1680-1689.
35. Tang Y, Luo J, Zhang W, and Gu W (2006). Tip60-dependent acetylation of p53 modulates the dedsion between cell-cycle arrest and apoptosis. MoI Cell 24, 827-839.
36. Squatrito M, Gorrini C, and Amati B (2006). Tip60 in DNA damage response and growth control: many tricks in one HAT. Trends Cell Biol 16, 433-442.
37. Gorrini C, Squatrito M, Luise C, Syed N, Perna D, Wark L, Martinato F, Sardella D, Verrecchia A, Bennett S, et al. (2007). Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature 446, 1063-1067.